The rationing of health
provisions is something that garners considerable controversy, so I felt it would be worthwhile to go into it in more detail.
Intuitively we might be lead to a
simple cost to benefit ratio system. Each treatment could have the years of
life, or better still years of life adjusted for quality, compared with its
cost. This could give a simple value of the cost per year of healthy life.
However, it cannot be so simple, in part because the use of one treatment may
in time lead to far more expensive care for an illness in later life, such as
dementia. A doctor I shadowed during the Summer actually suggested that, if the
NHS wanted to save money, they should encourage people to smoke so that people
died from acute rather than chronic diseases.
Ignoring the indirect effects for
now, here’s an example: A Primary Care Trust (or soon to be Clinical
Commissioning Group) has a portion of its funding left to spend, and has two
options. It can provide statins to all those with moderately raised cholesterol
levels thus reducing the risk of vascular or cardiac diseases slightly for each
individual, or artificial dialysis for all those in renal failure, which is
clearly saving lives directly. Both cost
the same, but spending the money on providing statins has a cost per healthy
year of, say, £10,000, whereas the figure for dialysis is £20,000. This
situation is simplistic and ignores the side effects of both, and the figures
are made up but not far from reality. In this context ‘Statins’ could be replaced
with any risk-reducing, preventative or early diagnostic measure, and
‘dialysis’ with any direct intervention with a greater cost to benefit ratio.
If we were only to use a simple ratio
we would consign those in renal failure to certain death in order that a much
larger number of people will have only a slightly reduced risk of disease
because the net benefit is greater if we provide statins. However, this seems
intuitively wrong to us, and the potential recipients of the statins would
likely prefer that the money be spent on providing dialysis rather than giving
them an insignificant reduction in personal risk.
The ethical dilemma of a cost to
benefit ratio is deepened when we consider groups such as the users of tobacco,
the overweight, the elderly and other at-risk groups. It seems reasonable that the
future prospect of life, which is often limited for, say, the elderly, should
also be factored into healthcare rationing decisions. The practical implication
of this would be that that the prior-mentioned groups may have certain
treatments withheld on the grounds that they will get less benefit than a
young, healthy person would. This runs against our intuitions about the need
for equality in healthcare provision, and again for providing care to those who
need it immediately.

So, do you agree with my
tentative conclusion? Do we base too much of our health policy on the rule of
rescue at the expense of healthcare? Where should we draw the line between expenditure
on public health and on treatment?
- Daniel